Clinical Trials
14 trialsNCT06357598 2024-04-10
PILOT
The Affiliated Hospital of Qingdao University
Phase 4 Unknown
NCT05603065 2023-06-29
TINES
First Affiliated Hospital Xi'an Jiaotong University
Phase 4 Unknown
NCT05730777 2023-02-16
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
Peking University Third Hospital
Phase 4 Unknown
NCT05312840 2022-04-06
Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer
People's Hospital of Quzhou
Phase 4 Unknown
NCT04999878 2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4 Unknown
NCT02996214 2020-02-13
LIPUSU
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT03071822 2018-06-11
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas
The University of Hong Kong
Phase 4 Unknown
NCT02348450 2016-12-05
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 4 Unknown
NCT02804646 2016-06-21
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
Phase 4 Unknown
NCT02031601 2016-03-29
TCL-1
Qilu Hospital of Shandong University
Phase 4 Unknown
NCT02513355 2015-08-04
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase 4 Unknown
NCT01501136 2015-07-17
CTTNKTL-I/II
Zhengzhou University
Phase 4 Unknown
NCT01424839 2015-06-04
SIOPCNSGCTII
University Hospital Muenster
Phase 4 Unknown
NCT00226473 2006-06-21
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Dermatologic Cooperative Oncology Group
Phase 4 Unknown